Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Survival Analysis: TACE vs. Combination Therapy in HCC
- Status
- COMPLETED
- Phase
- N/A
Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)
- Status
- RECRUITING
- Phase
- PHASE2
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
Targeted Navigation in Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Find HDV and Determine Its Status in Turkey
- Status
- RECRUITING
- Phase
- N/A
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
- Status
- RECRUITING
- Phase
- NA
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MGC026 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Immunotherapy for Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
- Status
- RECRUITING
- Phase
- NA
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis
- Status
- COMPLETED
- Phase
- PHASE2
Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant
- Status
- COMPLETED
- Phase
- N/A
TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Brazilian Reality of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1